pyruvic acid has been researched along with Cardiomyopathies in 11 studies
Pyruvic Acid: An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed)
pyruvic acid : A 2-oxo monocarboxylic acid that is the 2-keto derivative of propionic acid. It is a metabolite obtained during glycolysis.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with thiamine and carnitine resulted in a decrease in blood lactate to normal levels and a dramatic clinical improvement." | 5.28 | Neonatal cardiomyopathy and lactic acidosis responsive to thiamine. ( Abeling, NG; Bakker, HD; Lam, J; Luyt-Houwen, IE; Scholte, HR; van Gennip, AH, 1991) |
| "Treatment with thiamine and carnitine resulted in a decrease in blood lactate to normal levels and a dramatic clinical improvement." | 1.28 | Neonatal cardiomyopathy and lactic acidosis responsive to thiamine. ( Abeling, NG; Bakker, HD; Lam, J; Luyt-Houwen, IE; Scholte, HR; van Gennip, AH, 1991) |
| "Verapamil-treated myopathic hamsters had evidence of markedly improved mitochondrial function when compared with untreated animals." | 1.27 | Evaluation of the hereditary Syrian hamster cardiomyopathy by 31P nuclear magnetic resonance spectroscopy: improvement after acute verapamil therapy. ( Higgins, CB; James, TL; Jasmin, G; Markiewicz, W; Parmley, WW; Sievers, R; Wikman-Coffelt, J; Wu, SS, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Shimada, BK | 1 |
| Boyman, L | 1 |
| Huang, W | 1 |
| Zhu, J | 1 |
| Yang, Y | 1 |
| Chen, F | 1 |
| Kane, MA | 1 |
| Yadava, N | 1 |
| Zou, L | 1 |
| Lederer, WJ | 1 |
| Polster, BM | 1 |
| Chao, W | 1 |
| Hiraki, N | 1 |
| Tanaka, TD | 1 |
| Yoshimura, M | 1 |
| Mallet, RT | 1 |
| Sun, J | 1 |
| Knott, EM | 1 |
| Sharma, AB | 1 |
| Olivencia-Yurvati, AH | 1 |
| Zhao, G | 1 |
| Jeoung, NH | 1 |
| Burgess, SC | 1 |
| Rosaaen-Stowe, KA | 1 |
| Inagaki, T | 1 |
| Latif, S | 1 |
| Shelton, JM | 1 |
| McAnally, J | 1 |
| Bassel-Duby, R | 1 |
| Harris, RA | 1 |
| Richardson, JA | 1 |
| Kliewer, SA | 1 |
| Dionisi-Vici, C | 1 |
| Ruitenbeek, W | 1 |
| Fariello, G | 1 |
| Bentlage, H | 1 |
| Wanders, RJ | 1 |
| Schägger, H | 1 |
| Bosman, C | 1 |
| Piantadosi, C | 1 |
| Sabetta, G | 1 |
| Bertini, E | 1 |
| Ngai, SM | 1 |
| Way, MM | 1 |
| Chan, H | 1 |
| Tsui, SK | 1 |
| Lee, CY | 1 |
| Fung, KP | 1 |
| Wikman-Coffelt, J | 2 |
| Stefenelli, T | 1 |
| Wu, ST | 1 |
| Parmley, WW | 2 |
| Jasmin, G | 2 |
| Bakker, HD | 1 |
| Scholte, HR | 1 |
| Luyt-Houwen, IE | 1 |
| van Gennip, AH | 1 |
| Abeling, NG | 1 |
| Lam, J | 1 |
| Bachmann, E | 1 |
| Weber, E | 1 |
| Ruddy, TD | 1 |
| Shumak, SL | 1 |
| Liu, PP | 1 |
| Barnie, A | 1 |
| Seawright, SJ | 1 |
| McLaughlin, PR | 1 |
| Zinman, B | 1 |
| Markiewicz, W | 1 |
| Wu, SS | 1 |
| Higgins, CB | 1 |
| Sievers, R | 1 |
| James, TL | 1 |
1 review available for pyruvic acid and Cardiomyopathies
| Article | Year |
|---|---|
Metabolic cardioprotection by pyruvate: recent progress.
Topics: Animals; Antioxidants; Cardiomyopathies; Cardiotonic Agents; Humans; Myocardium; Pyruvic Acid | 2005 |
10 other studies available for pyruvic acid and Cardiomyopathies
| Article | Year |
|---|---|
Pyruvate-Driven Oxidative Phosphorylation is Downregulated in Sepsis-Induced Cardiomyopathy: A Study of Mitochondrial Proteome.
Topics: Animals; Cardiomyopathies; Male; Mice; Mitochondria; Mitochondrial Proteins; Myocardium; Oxidative P | 2022 |
A Man With Left Ventricular Hypertrophy.
Topics: Adult; Atrophy; Cardiomyopathies; Cerebellar Diseases; Cognitive Dysfunction; Echocardiography; Gluc | 2022 |
Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy.
Topics: Aging; Animals; Blotting, Western; Calcineurin; Cardiomyopathies; Humans; Lactic Acid; Mice; Mice, T | 2008 |
New familial mitochondrial encephalopathy with macrocephaly, cardiomyopathy, and complex I deficiency.
Topics: Cardiomyopathies; Electrophoresis, Gel, Two-Dimensional; Family Health; Fatal Outcome; Fibroblasts; | 1997 |
In silico studies of energy metabolism of normal and diseased heart.
Topics: Cardiomegaly; Cardiomyopathies; Computational Biology; Energy Metabolism; Expressed Sequence Tags; G | 2000 |
[Ca2+]i transients in the cardiomyopathic hamster heart.
Topics: Animals; Calcium; Cardiac Complexes, Premature; Cardiomyopathies; Cricetinae; Fluorescent Dyes; Fluo | 1991 |
Neonatal cardiomyopathy and lactic acidosis responsive to thiamine.
Topics: Acidosis, Lactic; Cardiomyopathies; Carnitine; Child; Child, Preschool; Female; Humans; Infant; Keto | 1991 |
Recirculating, retrograde heart perfusion according to Langendorff as a tool in the evaluation of drug-induced cardiomyopathy: effects of a high lipid diet.
Topics: Animals; Cardiomyopathies; Creatine Kinase; Dietary Fats; Energy Metabolism; Female; Glycogen; L-Lac | 1991 |
The relationship of cardiac diastolic dysfunction to concurrent hormonal and metabolic status in type I diabetes mellitus.
Topics: Adult; Blood Glucose; Cardiomyopathies; Diabetes Mellitus, Type 1; Diastole; Epinephrine; Female; Gl | 1988 |
Evaluation of the hereditary Syrian hamster cardiomyopathy by 31P nuclear magnetic resonance spectroscopy: improvement after acute verapamil therapy.
Topics: Adenosine Triphosphate; Animals; Cardiomyopathies; Cricetinae; Glucose; Hemodynamics; Hydrogen-Ion C | 1986 |